Adjuvant Capital β Full Portfolio
20 tracked investments Β· listed companies and verified rows first
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.
BiotechHealthtechMenlo Park, US
Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Joshua Eizen(Executive Officer)Sanjay Chanda(Chief Development Officer)
Co-investorsBioRock VenturesFlucas VenturesMountain Group CapitalRA CapitalHatteras Venture Partners
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone CapitalEQT Life Sciences+2 more
54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.
HealthtechWellness & FitnessLagos, NG
Gatumi Aliyu(Founder)inAbasi Ene-Obong(Founder)inOgochukwu Francis Osifo(Founder)in
Co-investorsEndeavor CatalystFifty YearsThe Raba PartnershipV8 Capital PartnersY Combinator
Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Karl Y. Hostetler(Executive Officer, Director)Gail Maderis(Director)Kristine Ball(Executive Officer, Director)Elaine Chien(Executive Officer)Sarah Walter(Executive Officer)Raju Gadiraju(Executive Officer)
Co-investorsBrace PharmaCanaan PartnersLumira VenturesMPM BioImpactOUP (Osage University Partners)Sofinnova Ventures+3 more
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)
BoardJustin Klein(Director)in
Co-investorsGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain AssociatesDomain Partners+2 more
Codagenix develops viral vaccines and virotherapeutics using codon deoptimization, a method for engineering attenuated viruses.
BiotechDeep TechHealthtechFarmingdale, US
John Robert Coleman(Executive Officer, Director)Steffen Mueller(Director)Charlie Petty(Director)Steven Winick(Director)Jill Howe(Director)Paul Grint(Director)
Co-investorsIn-Q-TelTopspin Partners
Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases.
BiotechHealthtech
George Simeon(CEO)Gregory S. Curhan(CFO)Guy De La Rosa(CMO)
Co-investorsOrbiMedRA CapitalSanofi VenturesHBM Healthcare InvestmentsJanus Henderson InvestorsMedicxi
Evofem Biosciences develops women's sexual and reproductive healthcare products, including PHEXX, an FDA-approved hormone-free, on-demand prescription vaginal gel contraceptive.
BiotechDigital HealthFemTech
Co-investorsAtinum Investment Co. Ltd.
Co-investorsAbstract VenturesCivilization Ventures Management, LlcCota CapitalGreatPoint VenturesNorwest Venture PartnersToba Capital+1 more
Frontier Nutrition makes fortified snacks aimed at improving pediatric and maternal nutrition, focusing on affordability and cultural relevance for low-income communities.
Advanced ManufacturingConsumerFoodTechImpact & Social GoodHastings On Hudson, US
Edward Bearnot(Chief Executive Officer)Tanveer Ali(Co-Founder & CFO, Director)Eddie Bearnot(Co-Founder & CEO, Chairman)Rob Beudeker(Director)Shazi Visram(Director)Paul Levy(Director)
Co-investorsStartup Bangladesh
X-vax Legend sells "Nagapetir" branded decorative stickers with various designs for use on motorcycles, cars, laptops, helmets, and community or brand promotion.
E-commerce
Co-investorsScientia Ventures
InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines.
BiotechHardwareHealthtechMedical DevicesBoulder, US
Kathy Rowlen(Co-founder, Scientific Advisor (former CEO))Shannon Rodriguez(Chief Operations Officer)Erica Dawson(Chief Technical Officer)Craig Hoechstetter(Chief Commercial Officer)Michael Chang(Director)Laura Kuck(Executive Officer)
Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases.
BiotechHealthtech
Co-investorsF-Prime Capital
LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAndera PartnersTenmile
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalFresenius Medical Care VenturesVerve Venturesredalpine
Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.
BiotechHealthtech
Pete Strong(Co-founder)Garth Rapeport(Co-founder)Kazuhiro Ito(Co-founder)John Murray(Co-founder)David Mantusin
Co-investorsF-Prime CapitalJeito CapitalLongwood FundSR One Capital ManagementSV Health InvestorsVivo Capital+2 more
Quantoom Biosciences develops a full-stack RNA platform, its N-Force toolbox (Ncode for sequence design, Ntensify for RNA production, and Ncapsulate for RNA formulation), to convert antigens into formulated mRNA and saRNA drug products.
BiotechDeep Tech
BiotechBoulder, US
Theodore Randolph(Director)Romulo Colindres(Executive Officer, Director, Promoter)
BoardGlenn Rockman(Director)Rene Lorenz(Director)Louise Brady(Director)
Co-investorsBuff Gold VenturesCU Healthcare Innovation FundRA Capital
VitriVax is a formulation technology company developing methods to improve the accessibility and utility of human vaccines.
BiotechHealthtech
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.